Zura Bio Ltd
8-K
March 19, 2026
Key Highlights
- Successfully raised $144 million (net $134.8 million) through a public stock off...
- Cash runway extended through at least the end of 2028, significantly reducing fi...
- Main drug, tibulizumab, is progressing in mid-stage human trials for hidradeniti...
Read Analysis
๐ค AI Generated